ASCO: Oxaliplatin does not improve outcomes for rectal cancer

Bookmark and Share
Published: 18 Jun 2009
Views: 12467
Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy
ASCO press conference: Adding oxaliplatin (Eloxatin) to standard treatment in patients with locally advanced rectal cancer does not improve tumour response. A preliminary analysis, however, suggests the treatment may reduce distant metastases.